drugset / Trial / NCT01649700

Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells

NCT01649700

Phase 1/2 Completed 1 enrolled National Yang Ming Chiao Tung University
NaSingle-groupOpen-labelTreatment

Summary

The study is to investigate the efficacy and safety of autologous transplantation of adipose-derived mesenchymal stem cells in patients with the sequelae caused by severe brain injury.

Timeline

Start
2011-10
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy 5e+07 cells
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy 7e+07 cells

Indications